Page last updated: 2024-10-28

hexetidine and 2019 Novel Coronavirus Disease

hexetidine has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Hexetidine: A bactericidal and fungicidal antiseptic. It is used as a 0.1% mouthwash for local infections and oral hygiene. (From Martindale, The Extra Pharmacopoeia, 30th ed, p797)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ogun, SA1
Erinoso, O1
Aina, OO1
Ojo, OI1
Adejumo, O1
Adeniran, A1
Bowale, A1
Olaniyi, CA1
Adedoyin, BM1
Mutiu, B1
Saka, B1
Oshinaike, O1
Arabambi, W1
Adejumo, F1
Shuaib, O1
Salmon, AO1
Abdur-Razzaq, H1
Njokanma, OF1
Ojini, O1
Ogboye, O1
Lajide, O1
Wright, KO1
Osibogun, A1
Abayomi, A1

Trials

1 trial available for hexetidine and 2019 Novel Coronavirus Disease

ArticleYear
Efficacy of Hexetidine, Thymol and Hydrogen Peroxide-Containing Oral Antiseptics in Reducing Sars-Cov-2 Virus in the Oral Cavity: A Pilot Study.
    West African journal of medicine, 2022, Jan-31, Volume: 39, Issue:1

    Topics: Adult; Anti-Infective Agents, Local; COVID-19; Hexetidine; Humans; Hydrogen Peroxide; Mouth; Pilot P

2022